Last reviewed 2026-06-10 · How we verify

Advanced Non-squamous NSCLC — Treatment Landscape & Competitive Intelligence

Advanced Non-squamous NSCLC (disease) competitive landscape: 0 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Marketed treatment landscape

Approved drugs treating Advanced Non-squamous NSCLC, deduplicated by molecule. See the full disease page for line-of-therapy detail.

No marketed treatments tracked for this disease yet.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

1. Pfizer Inc. · 1 drug in Advanced Non-squamous NSCLC

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Advanced Non-squamous NSCLC:

• Advanced Non-squamous NSCLC treatment updates — RSS
• Advanced Non-squamous NSCLC treatment updates — Atom
• Advanced Non-squamous NSCLC treatment updates — JSON

Cite this brief

Drug Landscape (2026). Advanced Non-squamous NSCLC — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/advanced-non-squamous-nsclc. Accessed 2026-06-10.

Related

• Advanced Non-squamous NSCLC full disease profile — treatment pathway, diagnostics, guidelines
• Browse all CI briefs
• Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing